A
Andy Gonzalez
Vitreoretinal surgeon at Mann Eye Institute (Houston) and founder of Retinex, an AI-native EMR for ophthalmology.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
Oct 8, 2026
Retinex and the Rebuild of the Ophthalmology Workflow
F
7:33Firas RahalHOST
But what do you see as some of the technical or practical challenges that are there now? We all feel them, but how, how have you viewed this?
A
7:42Andy GonzalezGUEST
You know, in ophthalmology and vitreoretinal, there are some dominant platforms.
A
7:48Andy GonzalezGUEST
I don't wanna get into them specifically because, again, they're great companies run by great people.
A
7:53Andy GonzalezGUEST
They've served the specialty for a long time, so let's focus on the pitfalls and problems.
A
7:59Andy GonzalezGUEST
I don't personally believe their software is built for the era of AI and interoperability that we're now entering, and it's not just me saying this either.
20 MINS LATER
F
28:22Firas RahalHOST
Uh, is there an approval process? What is it? And where are you in the corporate structure building, corp- team building at this point?